Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

  1. Lainez, N.
  2. García-Donas, J.
  3. Esteban, E.
  4. Puente, J.
  5. Sáez, M.I.
  6. Gallardo, E.
  7. Pinto-Marín, null
  8. Vázquez-Estévez, S.
  9. León, L.
  10. García-Carbonero, I.
  11. Suárez-Rodríguez, C.
  12. Molins, C.
  13. Climent-Duran, M.A.
  14. Lázaro-Quintela, M.
  15. González del Alba, A.
  16. Méndez-Vidal, M.J.
  17. Chirivella, I.
  18. Afonso, F.J.
  19. López-Brea, M.
  20. Sala-González, N.
  21. Domenech, M.
  22. Basterretxea, L.
  23. Santander-Lobera, C.
  24. Gil-Arnáiz, I.
  25. Fernández, O.
  26. Caballero-Díaz, C.
  27. Mellado, B.
  28. Marrupe, D.
  29. García-Sánchez, J.
  30. Sánchez-Escribano, R.
  31. Fernández Parra, E.
  32. Villa Guzmán, J.C.
  33. Martínez-Ortega, E.
  34. Belén González, M.
  35. Morán, M.
  36. Suarez-Paniagua, B.
  37. Lecumberri, M.J.
  38. Castellano, D.
  39. Show all authors +
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2016

Volume: 16

Issue: 1

Type: Article

DOI: 10.1186/S12885-016-2084-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus